HUTCHMED (China) Ltd
HKEX:13
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
HK |
|
L
|
Lubawa SA
WSE:LBW
|
PL |
|
F
|
Forte Minerals Corp
CNSX:CUAU
|
CA |
|
Roolife Group Ltd
ASX:RLG
|
AU |
|
Sat Industries Ltd
BSE:511076
|
IN |
|
A
|
argenx SE
F:1AE
|
NL |
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
|
NZ |
|
Symbotic Inc
NASDAQ:SYM
|
US |
|
Morella Corporation Ltd
ASX:1MC
|
AU |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
CleanBnB SpA
MIL:CBB
|
IT |
|
D
|
Duk San Neolux Co Ltd
KOSDAQ:213420
|
KR |
|
O
|
Orkla ASA
XMUN:OKL
|
NO |
|
S
|
Sixt SE
DUS:SIX3
|
DE |
Bankruptcy Probability
HUTCHMED (China) Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
HUTCHMED (China) Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HK |
H
|
HUTCHMED (China) Ltd
HKEX:13
|
18.4B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
2.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
344.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
268.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
HUTCHMED (China) Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, HUTCHMED (China) Ltd has total debt of 90.3m USD. This includes both short-term (18.2m USD) and long-term (72.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
